Eleanor Price

Eleanor Price is an investment analyst at Thuja Capital. Eleanor has over six years of experience in the healthcare and life sciences industry, having worked in strategic consulting and technology translation.

Eleanor began their career as a partner at Panacea Innovation, where they managed the overall operations of PanaceaStars, a healthcare and life sciences technology translation platform. Eleanor also directed the operations of PanaceaStars’ portfolio companies over the course of the 3-month ‘de-risking’ programme, Develop.

In January 2020, Eleanor joined IQVIA as an Associate Consultant in IQVIA Financial Institutions Consulting. In this role, they perform commercial due diligence for financial institutions to support investments in life sciences. Prior to this, they worked on a broad range of strategic projects for healthcare and life science clients, covering portfolio, brand and launch strategy, digital health and market access.

Starting with their most recent degree, Eleanor Price earned a Doctor of Philosophy in Cardiovascular Regenerative Medicine from the University of Oxford. Prior to that, they earned a Master of Business Administration from Quantic School of Business and Technology. Her undergraduate degree is a Bachelor of Science in Cellular and Molecular Medicine from the University of Bristol. Eleanor also holds degrees from The Sixth Form College Farnborough and Edgbarrow School.